Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Overexpression of Oncogenic Inhibitory-ASPP (inhibitor of apoptosis stimulating protein of p53) Results in Therapy Resistance and Adverse Outcome in AML

Marcus Matthias Schittenhelm, Mihada Bajrami Saipi, Gunnar Blumenstock, Peter JM Valk, Balazs Györffy, Kerstin Maria Kampa-Schittenhelm

Blood (2022) 140 (Supplement 1): 3433–3434.

https://doi.org/10.1182/blood-2022-170405

Published: 2022

Journal Articles

Attenuation of the Apoptosis Stimulating Protein of TP53-1 (ASPP1) Is a Predictive Marker for Therapy Resistance and Overall Survival in Acute Myeloid Leukemia (AML)

Marcus M. Schittenhelm, Max Kaiser, Vasileia Tsintari, Gunnar Blumenstock, Balazs Györffy, Kerstin Maria Kampa-Schittenhelm

Blood (2021) 138 (Supplement 1): 1298.

https://doi.org/10.1182/blood-2021-152531

Published: 2021

Journal Articles

Dysregulation of the ASPP Protein Family (Apoptosis Stimulating Proteins of TP53) Is a Common Feature in High-Risk Acute Myeloid Leukemia (AML)

Kerstin Maria Kampa-Schittenhelm, MD, Max Kaiser, Mihada Bajrami Saipi, Bianca Walter, Gunnar Blumenstock, Lothar Kanz, Marcus M Schittenhelm, MD

Blood (2017) 130 (Supplement 1): 1231.

https://doi.org/10.1182/blood.V130.Suppl_1.1231.1231

Published: 2017

Journal Articles

Attenuation of Apoptosis Stimulating Protein of p53-1 (ASPP1) Associates with Therapy Failure in Acute Myeloid Leukemia (AML)

Marcus M. Schittenhelm, Max Kaiser, Gunnar Blumenstock, Kerstin Maria Kampa-Schittenhelm, MD

Blood (2016) 128 (22): 1556.

https://doi.org/10.1182/blood.V128.22.1556.1556

Published: 2016

Journal Articles

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Marcus M Schittenhelm, Dr., MD, Barbara Illing, Figen Akmut, Gunnar Blumenstock, Konstanze Döhner, MD, Charles D Lopez, MD, PhD, Kerstin M Kampa-Schittenhelm, Dr., MD

Blood (2013) 122 (21): 3770.

https://doi.org/10.1182/blood.V122.21.3770.3770

Published: 2013

Journal Articles

Incidence and Characterization of Taste Disturbances After Allogeneic or Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-Intensity-Conditioning.

Birgit Federmann, MD, Jens Weidmann, Gunnar Blumenstock, MD, Silke Schwarz, Lothar Kanz, MD, Frank Mayer, MD, Wolfgang Andreas Bethge, MD

Blood (2009) 114 (22): 3319.

https://doi.org/10.1182/blood.V114.22.3319.3319

Published: 2009

NARROW

Overexpression of Oncogenic Inhibitory-ASPP (inhibitor of apoptosis stimulating protein of p53) Results in Therapy Resistance and Adverse Outcome in AML

Attenuation of the Apoptosis Stimulating Protein of TP53-1 (ASPP1) Is a Predictive Marker for Therapy Resistance and Overall Survival in Acute Myeloid Leukemia (AML)

Dysregulation of the ASPP Protein Family (Apoptosis Stimulating Proteins of TP53) Is a Common Feature in High-Risk Acute Myeloid Leukemia (AML)

Attenuation of Apoptosis Stimulating Protein of p53-1 (ASPP1) Associates with Therapy Failure in Acute Myeloid Leukemia (AML)

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Incidence and Characterization of Taste Disturbances After Allogeneic or Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-Intensity-Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Overexpression of Oncogenic Inhibitory-ASPP (inhibitor of apoptosis stimulating protein of p53) Results in Therapy Resistance and Adverse Outcome in AML

Attenuation of the Apoptosis Stimulating Protein of TP53-1 (ASPP1) Is a Predictive Marker for Therapy Resistance and Overall Survival in Acute Myeloid Leukemia (AML)

Dysregulation of the ASPP Protein Family (Apoptosis Stimulating Proteins of TP53) Is a Common Feature in High-Risk Acute Myeloid Leukemia (AML)

Attenuation of Apoptosis Stimulating Protein of p53-1 (ASPP1) Associates with Therapy Failure in Acute Myeloid Leukemia (AML)

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Incidence and Characterization of Taste Disturbances After Allogeneic or Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-Intensity-Conditioning.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only